Surmodics Inc. (SRDX): Enterprise Value to EBITDA Ratio
Surmodics, Inc. (SRDX) is implementing automation in the creation of precision medical coatings, eliminating human error during sterilization. High innovation margins and growing shipment volumes create powerful operating leverage, reducing R&D costs. This chart shows that EV/EBITDA is 65.02. The business relies on licensing its patents, generating stable royalties from partners with minimal internal costs.
Comprehensive metric breakdowns and analytics for surmodics.com (SRDX)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
SRDX - Net Financial Result|Projected Future Earnings Surmodics, Inc.|SRDX - Price to Earnings Ratio|Forward P/E Multiple Surmodics, Inc.|SRDX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc.|SRDX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Surmodics|SRDX - Earnings per share for the trailing year|Quarterly EPS earnings growth surmodics.com|SRDX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Surmodics, Inc.
Analysis of all company metrics:Surmodics Corp SRDX
The high degree of production automation for coatings at Surmodics, Inc. (SRDX) requires significant capital expenditures, which this multiple reflects. It compares the total enterprise value, including debt, to operating profit before depreciation and amortization (EBITDA). By analyzing the EV/EBITDA valuation level, an investor determines whether the market price is fair relative to the assets' actual ability to generate cash flow. This allows for an assessment of the efficiency of the company's technological upgrades.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings Inc SENS|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio KNW|EV/EBITDA Multiple Inari Medical Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|RSLS (reshapelifesciences.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
